Clinical Trial Update: Cognitive Effects of Roflumilast in (a)MCI and Mild Dementia Patients [Phase 2]

View source ↗

Summary

Phase 2 study updating cognitive effects of roflumilast in mild cognitive impairment and mild dementia patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Dementia

Drugs mentioned

• Roflumilast (roflumilast)

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Mild Cognitive Impairment, Mild Dementia | Phase 2 | Status: UNKNOWN